Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

Exclusion Criteria

• •Current diagnosis of organic uterine bleeding
• •History of endometrial ablation, or dilatation and curettage within 2 months of Visit 1.
• •Clinically significant pelvic findings (whether or not confirmed by transvaginal ultrasound \[TVU\]).
• •Clinically significant abnormal results of breast examination (breast palpation).
• •Positive pregnancy test at Visit 1
• •Less than three months since delivery, abortion, or lactation before to start Visit 1
• •Other contraceptive methods
• •Any disease or condition that may worsen under hormonal treatment
• •Smokers over the age of 35
• •Body mass index \>32